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INTRODUCTION. 
The prototypic Mitogen Activated Protein Kinase (MAPK) 
pathway consists of a three-tiered module composed of a 
MAPK (ERK-1/2), which is activated via phosphorylation 
by a MAPKK (MEK-1/2), which in turn is phosphorylated 
by a MAPKKK (Raf). This pathway exists in all eukaryotic 
organisms and controls fundamental cellular processes such 
as proliferation, differentiation, migration, survival, and 
apoptosis [1-3]. Importantly, the cascade arrangement of 
this module permits integration of a wide range of con-
served cellular process, thereby enabling a precise control of 
the amplitude, kinetics, and duration of ERK-1/2 (ERK) 
activation. Several studies have documented that it is the 
ability to modulate these individual parameters of ERK ac-
tivation that confers signaling specificity to this pathway, in 
terms of regulating the cellular response [4-7]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     The contrast between the apparent biochemical simplic-
ity of this pathway, and the range of complex cellular func-
tions that it controls, has prompted extensive investigations 
on the structure and regulation of this pathway. One ap-
proach towards this goal has been through computational 
modeling of this pathway. The earliest model by Huang and 
Ferrell demonstrated that ERK activation exhibited ultrasen-
sitivity, and that this was primarily due to the distributive 
mechanism involved in the dual phosphorylation of ERK 
[8,9]. Subsequent to these pioneering findings, an increasing 
number of models that have gained both in size and com-
plexity have been developed over the years. The various 
aspects examined by these models include feedback coop-
erativity and inhibition, hysteresis, oscillations, Ras activa-
tion, scaffolding proteins, signal specificity and robustness 
among others  [10-13].  From the standpoint of input/output 
relationships, these models have provided important new 
insights on feedback, sequestration, and scaffolding influ-
ences on the ERK response [14-17].  
     A less explored aspect of MAPK regulation, however, 
has been the role of phosphatases in regulating signal speci-
ficity [18]. An earlier study by Bhalla and co-workers iden-
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tified MAPK phosphatase (MKP) as the locus of flexibility 
that regulated between monostable and bistable regimes of 
operation [19]. More recently, the protein tyrosine phos-
phates (PTP) SHP-1 was shown to be critical for defining 
the ligand discrimination threshold of the ERK response in 
T lymphocytes [20]. Nonetheless, in view of the multiple 
phosphatases known to be associated with components of 
the MAPK pathway, a more integrated view of how such 
phosphatases regulate input/output relationships is presently 
lacking[21].  
     Our earlier study in murine B lymphoma A20 cells had 
demonstrated that the B cell antigen receptor (BCR)-
dependent phosphorylation profiles of all the three constitu-
ents of the MAPK module (i.e. Raf. MEK-1/2 and ERK-1/2) 
were profoundly influenced when cells were depleted of a 
range of cellular phosphatases by siRNA [22]. Interestingly, 
depending upon the phosphatase depleted, these effects 
were either positive or negative suggesting diverse modes of 
regulation. Therefore, in the present study, we integrated 
this experimental data with existing literature to generate a 
mathematical model for ERK phosphorylation. The result-
ing model revealed an additional level of regulation of the 
MAPK pathway, which was enforced through the parallel 
alignment of a cascade of phosphatases. Importantly, the 
crosstalk between the MAPK and the phosphatases cascade 
led to the assembly of a novel regulatory motif that enabled 
independent calibration of signal at each successive node. 
As a result signal transmission through the MAPK pathway 
was non-linear, leading to a combinatorial expansion of the 
landscape of potential output responses. Significantly, in 
addition to parameters such as signal strength and duration, 
the bounds of this landscape also incorporated variations in 
the relative levels (or, activities) of the associated phos-
phatases. Thus, our studies identify a novel processing prin-
ciple as a result of which the signal output represents an 
integrated expression of the properties of the stimulus, and 
the phenotypic status of the cell. 
 
RESULTS. 
 
Modeling BCR-dependent activation of the MAPK net-
work. 
Our previous experimental studies of the plasticity of the 
BCR signaling network, and its response to specific pertur-
bations [22-24], provided us with an internally normalized 
dataset for modeling salient features of the signaling net-
work. We, therefore, combined these results with data from 
the literature to develop a block diagram for the BCR-
activated MAPK signaling network. Here we specifically 
included the results from our most recent experiments prob-
ing the consequences of siRNA-mediated depletion of vari-
ous cellular phosphatases, on BCR-dependent phosphoryla-
tion of the constituents of the MAPK pathway [22]. Data 
generated from the depletion of five of the tested phosphata-
ses were taken for this study, and these five phosphatases 
were: PP1, PP2A, MKP1, MKP2, and MKP3. The selection 
of these phosphatases was guided by the fact that MKPs 
are known regulators of phoshorylation of the intermediates 
in the MAPK pathway [19,25,26]. Further Raf, MEK, 
MKP1 and MKP3 are all regulated through phosphorylation 
at Ser/Thr residues [25,27], thereby implicating a possible 
role for PP1 and PP2A. 
     Modeling of BCR mediated signal transduction involved 
the basic reaction scheme from the receptor, to the interme-
diate molecules leading to the MAPK pathway and, eventu-
ally, to the regulation of ERK (a detailed description of the 
model development, parameter estimation, and sensitivity 
and robustness analyses are provided in Supplementary Data 
S1) (Fig1A). This process involved several rounds of itera-
tions before the model could completely reproduce the ex-
perimental dataset, which involved upstream kinases and 
phosphatases apart from the core MAP kinase module. 
Model parameters such as initial concentrations, Km and Kd 
values, and other rate parameters were either taken from 
literature or, when not available, were optimized for produc-
ing the best experimental fit. The model incorporated ge-
neric rate laws such as mass action and Michaelis-Menten 
reaction schemes to represent the interactions among the 
species. The system was taken as appropriately modeled 
when it could fit the experimental phenotypic data (e.g. the 
previous results of our siRNA experiments), which included 
both the upstream and the MAPK intermediates. Apart from 
the general schematic (Fig 1A) of BCR signal transduction 
leading to ERK, the core MAPK module regulated by cellu-
lar phosphatases (Fig 1B) was of our interest for analysis. 
Care was taken to incorporate these phosphatases in the 
network in a manner that was consistent with the known 
literature information and, in cases where adequate informa-
tion was not available, assumptions were made based on our 
own experimental data to fit the phosphatases. Overall, the 
model consisted of 158 variables representing different 
pools of molecules, 172 biochemical reactions, and 256 total 
parameters (see Supplementary Data S1).  
     The resulting model was fairly complex, encompassing 
the span of regulatory events emanating from the receptor 
and terminating at ERK (Fig. 1A &B). To test the model, 
we performed Local and Global Sensitivity analyses using 
several independent methods to evaluate the parameters for 
their robustness against fluctuations that are inherent to 
noisy biological conditions. We found that parameters that 
were most sensitive were those that are already known to be 
critical for shaping the BCR-specific signaling response. In 
other words, our model indeed reflected the true kinetic 
properties of BCR-dependent signaling. Parameters specific 
for the MAPK-phosphatase module (see Fig. 1B) were ro-
bust in terms of the output behavior, and could tolerate a 
broad range of perturbations against the ERK activation 
response. Further, we also verified that the robustness of our 
model compared well with that of other prominent models 
described for the MAPK pathway (see Supplementary Data 
S1). At the experimental level, the model also successfully 
recapitulated results available in the literature, which in-
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cluded our own earlier experimental data on BCR-
dependent signaling in A20 cells (Supplementary Data S2 
and S3).  
 
Analysis of the model. 
The model described in Figure 1A exhibited several intrigu-
ing topological and dynamical features. This is especially 
evident from Figure 1B, which highlights the co-alignment 
of a phosphatase cascade alongside the MAPK pathway, 
leading to several cross-regulatory interactions between the 
two. Notably, these interactions also included two novel 
links for MKP3. That is, in addition to ERK, our model de-
scribed MKP3 to also interact with – and negatively regulate 
- MEK and MKP1 (Fig. 1B). Further, another related pre-
diction by the model was that MKP3-dependent regulation 
was tightly controlled through a modulation of its substrate 
bias. In other words, while phosphorylated MKP3 was de-
scribed to exhibit a preference for MEK and MKP1, its non-
phosphorylated form was predicted to be more selective for 
ERK (see Supplementary Data S1). As a result, shifts in the 
distribution of MKP3 between the phosphorylated and non-
phosphorylated pools potentially served as a mechanism for 
diversifying the influence of MKP3 on MAPK signaling. 
      An in silico prediction of the time-dependent profile of 
ERK phosphorylation was consistent with the experimen-
tally obtained results (Fig. 2A). Further, a similar in silico 
analysis of ERK phosphorylation in response to varying 
ligand concentrations yielded an incremental dose-response 
response profile (Fig. 2B). This prediction of a graded ERK 
output could also be experimentally confirmed by stimulat-
ing A20 cells with increasing concentrations of anti-IgG 
(Supplementary Data S4). Importantly, ERK response to 
ligand dose was found to be graded regardless of whether it 
was monitored at the level of the cell population by Western 
blot analysis (Fig. 2C), or at the level of single cells through 
intracellular staining for phospho-ERK and detection by 
flow cytometry (Fig. 2D). 
 
Experimental verification of the model. 
We have already noted earlier that our completed model for 
the BCR-dependent activation of ERK retained its ability to 
describe the activation profiles of the intermediates in a 
manner that was consistent with the experimental data. Fur-
ther, predictions on both the kinetics of ERK phosphoryla-
tion, and on the graded nature of the ERK response could 
also be subsequently borne out by experiment. Collectively 
these results would seem to support the veracity of our 
model, as well its sensitivity to perturbations in a context 
dependant manner. Nonetheless, it was also necessary to 
additionally confirm some of the topological features of the 
model, and their contribution to the systems properties of 
the MAPK module. 
     As shown in Figure 1B, a significant aspect of our model 
was the description of MKP3 as an important regulator of 
MAPK signaling through its ability to regulate MEK, ERK, 
and MKP1. While the interactions between MKP3 and ERK 
are well known [28], the MKP3-MEK and MKP3-MKP1 
interactions represent novel links identified here. We, there-
fore, sought to verify the existence of these latter links by 
performing co-immunoprecipitation experiments from lys-
ates of A20 cells, using antibodies specific either for MEK, 
MKP1, or MKP3. As shown in Figure 3A, immunoprecipi-
tation of either MEK or MKP1 also led to the simultaneous 
enrichment of MKP3, whereas immunoprecipitates of 
MKP3 were enriched for both MEK and MKP1. Although 
immunoprecipitation results do not permit quantification 
they, nonetheless, support at least the existence of MKP3 in 
a simultaneous complex with MKP1 and MEK, thereby 
confirming the interactions depicted in Figure 1B. In subse-
quent experiments we observed that the siRNA-mediated 
depletion of MKP3 resulted in a significant (~ 4-fold) in-
crease in the basal levels of MKP1 (Fig. 3B and Supplemen-
tary Data S4). These levels were further increased upon 
stimulation of cells through the BCR (Fig. 3B). The stability 
of intracellular MKP1 is dictated by its phosphorylation 
status. While the non-phosphorylated form exhibits a short 
half-life, phosphorylation enhances its stability [25]. Thus 
the observed inverse relationship between MKP3 and 
MKP1 levels in Figure 3B provides additional support for 
the functional nature of the link between these two phos-
phatases. In this connection it is pertinent to note that under 
condition of MKP3 silencing, the level of both phosphory-
lated ERK and p38 are significantly reduced following re-
ceptor stimulation [22]. Thus, the increased stability of 
MKP1 observed here, following MKP3 silencing, is more 
likely due to reduced de-phosphorylation of MKP1 by 
MKP3. 
     To verify whether the phosphorylation status of MKP3 
indeed modulated its substrate-specificity, we also examined 
anti-IgG-mediated stimulation of A20 cells in the presence 
of the CK2α inhibitor, DRB [29]. As shown in Figure 1B, 
MKP3 is primarily phosphorylated by CK2α. Inhibition of 
this kinase, therefore, leads to a concomitant inhibition of 
MKP3 phosphorylation [27]. According to our model then, 
this should then also result in an increased efficiency of 
MKP3-mediated dephosphorylation of ERK. As expected, 
stimulation of DRB-treated cells led to inhibition of BCR-
dependent phosphorylation of ERK (Fig. 3C and Supple-
mentary Data S4). These results are also consistent with 
previous findings that CK2α dependent phosphorylation of 
MKP3 attenuates its inhibitory effect on ERK phosphoryla-
tion [27]. 
      Although the results in Figure 3C provided experimental 
support for our proposal that MKP3 displays differential 
substrate specificity depending upon its phosphorylation 
status, we wanted to further establish this using an alternate 
and more direct approach. For this we again stimulated A20 
cells through the BCR, but either in the presence or absence 
of the CK2α-inhibitor, DRB. Following this, we then em-
ployed confocal microscopy to determine the effects of 
CK2α-inhibition on the co-localization of MKP3 with ERK, 
MEK, and MKP1. Figures 3D and E show that, in stimu-
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lated cells, inhibition of CK2α resulted in a substantial in-
crease in the extent of co-localization between MKP3 and 
ERK. In contrast, co-localization of MKP3 with both MEK 
and MKP1 was significantly reduced (Figure 3D & E). Es-
sentially similar results were also obtained in experiments 
where, instead of inhibition, CK2α was also specifically 
silenced through targeted siRNA (not shown). At one level 
these results provide direct evidence for the novel links be-
tween MKP3 and MEK, and between MKP3 and MKP1 
revealed by our model. In addition to this, however, the ob-
served alterations in the relative extents of co-localization of 
MKP3 with ERK, MEK, and MKP1 – induced by the inhi-
bition of CK2α-dependent phosphorylation of MKP3 - also 
provide clear experimental confirmation for our proposal 
that the substrate specificity of MKP3 is influenced by its 
phosphorylation status. 
     Collectively then, both the consistency between pre-
dicted and experimentally obtained phosphorylation profiles 
of the various signaling intermediates described above, as 
well as the experimental confirmation of the new MKP3-
dependent regulatory links proposed, provide experimental 
support for the model depicted in Figure 1A. 
 
Signal-dependent assembly of the MAPK cascade into a 
unique regulatory module. 
According to the model in Figure 1B, each intermediate in 
the MAPK pathway was under the regulatory control of 
both the co-aligned, and its immediately upstream, phos-
phatase. Thus, MEK was regulated by both PP2A and 
MKP3, whereas ERK was regulated by MKP3 and MKP1 
(Fig. 1B). The entire model consisted of links that collec-
tively belonged to all of the four possible categories; activa-
tion of activator (PKC to Raf, and Raf to MEK), inhibition 
of activator (PP2A to Raf, and MKP3 to MEK), activation 
of inhibitor (PKC to MKP3, and ERK to MKP1), and inhi-
bition of inhibitor (PP2A to MKP3 and MKP3 to MKP1, 2) 
(Fig. 1A and 1B).       
     A particularly striking aspect here was that co-alignment 
of the two cascades resulted in the generation of a novel 
regulatory motif that was composed of a contiguous set of 
two square units. The first of these consisted of Raf, MEK, 
PP2A, and MKP3 as the vertices, whereas the second unit 
involved MEK, ERK, MKP3, and MKP1 (Fig. 1B). Further, 
the linkage relationships between the corresponding vertices 
were also replicated (Fig. 1B). Interestingly, a closer inspec-
tion of this motif revealed that it was in fact composed of 
four smaller regulatory units (each triangle in the motif) that 
represented alternately placed type-2 coherent and incoher-
ent feedforward loops (FFLs, defined as in [30]. A more 
detailed analysis of these sub-structures, and their individual 
contributions to the overall properties of the parent motif is 
currently under way as a separate study. In this report we 
focused solely on the role of the larger motif, in regulating 
signal processing by the MAPK cascade.  
     Assembly of this regulatory motif required two sepa-
rate input signals originating from the BCR. The first of 
these was a PKC- and RasGTP-dependent AND gate that 
mediated Raf activation in a signal-dependent manner 
[19,31]. The second input signal was defined by the CK2α-
dependent phosphorylation of MKP3 (Fig. 1B). It has previ-
ously been demonstrated that MKP3 and CK2α form a pro-
tein complex wherein CK2α specifically phosphorylates 
MKP3, with the corresponding increase in ERK-2 phos-
phorylation [27]. As discussed later, the regulation of MKP3 
between its phosphorylated and non-phosphorylated states 
has significant implications for signal processing by the 
MAPK pathway. Finally, phosphorylation of MKP1 by 
ERK was also a prerequisite for the assembly of this motif, 
signifying the importance of crosstalk between these two 
cascades in this process. 
        
Phosphatase-mediated regulation of the ERK response. 
We first examined how the connected network of phos-
phatases influenced signal output from the MAPK module. 
This was achieved through in silico experiments examining 
the ligand dose-dependency of ERK phosphorylation, under 
conditions where the individual phosphatases were depleted 
one at a time. Figure 4 shows the results of these experi-
ments where panel A depicts the profile obtained in the un-
perturbed condition. It is evident that, with the exception of 
PP1, no other phosphatase depletion had any significant 
effect on the proportional nature of ERK activation (Fig. 4), 
The observed effect of PP1 depletion is consistent with our 
earlier experimental findings involving depletion of this 
enzyme by siRNA. In these experiments, a marked decrease 
in the magnitude of ERK activation was obtained at the later 
time points [22]. Thus these results indicate that PP1 may 
play an important role in buffering the inactive pool of hy-
per-phosphorylated Raf, which is generated by activated 
ERK through a positive feedback loop, and Akt [19,32,33].  
     Depletion of any of the remaining phosphatases resulted 
only in a modulation of the amplitude of ERK phosphoryla-
tion, with MKP1 depletion yielding the most pronounced 
effect (Fig. 4). Notable, however, were the qualitatively 
distinct effects seen upon depletion of the individual, 
MAPK-associated, phosphatases. Suppression of PP2A ex-
pression yielded a marginal effect on the shape of the dose 
response curve (Fig. 4), whereas that of MKP3 resulted in a 
diminished activation window for ERK due to a simultane-
ous increase in sensitivity to lower ligand concentrations, 
and a decrease in the peak level that was achieved (Fig. 4). 
In contrast, removal of MKP2 induced a comparable in-
crease in both the upper and lower bounds of ERK activity 
(Fig. 4). Thus, selective depletion of each of the phosphata-
ses exerted its own individual effect on the ligand-
dependent dose-response profile of ERK activation.  
      
Perturbation in phosphatase concentrations modulates 
the MAPK response. 
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The output of a signaling network is primarily determined 
by the topology of the network, and the concentrations of its 
nodal constituents. As shown in Figure 4, the topological 
allocation clearly had a significant bearing in terms of defin-
ing the extent of regulation that each phosphatase exerted on 
the MAPK signaling pathway. We, therefore, next examined 
how variations in the concentration of these phosphatases 
would impact on BCR-initiated MAPK signaling. This in-
volved in silico experiments in which the concentration of 
the individual phosphatase was varied from one that was 
ten-fold lower, to one that was ten-fold higher than its con-
stitutive level in A20 cells. The phosphorylation of both 
MEK-1/2 and ERK were examined under these conditions. 
     While such experiments were also carried out for PP1 
and MKP2 (see Supplementary Data S5), only the results 
obtained for the three phosphatases that are incorporated in 
the ‘two-square’ structural motif are shown in Figure 5. The 
figure describes the effect of varying the concentration of 
these individual phosphatases, on the peak levels of MEK 
and ERK phosphorylation. Of particular note here was the 
fact that changing PP2A concentrations exerted dissimilar 
effects on MEK and ERK. A bimodal effect was observed 
for MEK and this feature was retained at all strengths of 
signal (i.e. ligand doses) employed (Fig. 5). Contrary to this, 
ERK yielded a PP2A-dependent bimodal profile only at low 
ligand concentrations while the response to this phosphatase 
became linear as the signal strength was increased (Fig. 5). 
Thus, PP2A-mediated regulation imparted non-identical 
effects on these two – consecutively positioned - signaling 
intermediates of the MAPK pathway. Further, the extent of 
deviation in behavior between these two intermediates was 
also dependent upon the strength of the stimulus at the 
BCR.            Increasing PP2A concentrations also led to a 
progressive reduction in the amplitude of both MEK and 
ERK responses although the effect on the latter molecule 
was more pronounced (Fig. 5). This aspect could be experi-
mentally verified by stimulating A20 cells in the presence of 
the PP2A inhibitor okadaic acid (OA). Although OA is a 
known inhibitor of both PP2A and PP1, the 100-fold lower 
IC50 value for PP2A allowed us to use a concentration range 
that was specific for PP2A. 
     As shown in Supplementary Data S6, while inhibition of 
PP2A activity led to a linear increase in ERK phosphoryla-
tion, that of MEK shows a bimodal response to PP2A (also 
Figure 7A). The sensitivity of ERK to PP2A activity likely 
derives from the concomitant decrease in the size of the 
pool of non-phosphorylated MKP3, as a result of decreasing 
PP2A levels. As discussed earlier, this would decrease the 
efficiency of MKP3-dependent dephosphorylation of ERK. 
In addition to this, however, a diminished pool of phospho-
MKP3 would also imply a consequent reduction in the 
negative regulation of MKP1 and, thereby, an increase in 
the MKP1-dependent inactivation of ERK.  
     In similar experiments where MKP3 concentrations were 
varied, we observed an inverse relationship between the 
amplitude of MEK phosphorylation and MKP3 concentra-
tions. In contrast to this, ERK activation displayed a bell-
shaped profile (Fig. 5). The curvature of the bell was, how-
ever, more pronounced at higher ligand concentrations sup-
porting that ERK activation remained responsive to the 
strength of the stimulus. The bimodal effect of MKP3 on 
ERK activation again probably reflects the consequence of 
concentration-dependent shifts in the distribution of MKP3 
between its phosphorylated and non-phosphorylated states. 
At low concentrations, the non-phosphorylated form of 
MKP3 would predominate due to the dominant action of 
PP2A. The increased specificity of this form for ERK can 
then explain the reduced levels of peak ERK phosphoryla-
tion. As MKP3 levels increase, however, the proportion of 
its phosphorylated form is also expected to increase. The 
consequences of this on ERK activation would then be de-
fined by the balance of the effects of MKP3 on ERK, and 
that of phospho-MKP3 on MEK and MKP1 respectively. 
Thus, MKP3 negatively regulates ERK activity by ensuring 
its dephosphorylation. In contrast, phospho-MKP3 preferen-
tially targets MEK and MKP1 but with opposing conse-
quences. While MEK inactivation also inhibits transmission 
of signal to ERK, the dephosphorylation and consequent 
destabilization of MKP1 diminishes the negative regulation 
of ERK by this enzyme. It is the quantitative shifts in bal-
ance between these distinct activities that would then shape 
the ERK response to variations in MKP3 concentrations. 
     Consistent with expectations, increasing MKP1 levels 
led to a steep decline in peak levels of ERK phosphorylation 
whereas the effect on MEK was only marginal (Fig. 5). 
Thus the cumulative results in Figure 5 emphasize that sig-
nal-dependent formation of the “two-square” motif enables 
tight regulation of the MAPK signaling by the associated 
phosphatases. Importantly, both quantitative and qualitative 
aspects of signal transmission between two consecutive 
nodes were selectively influenced, thereby, providing a 
mechanism by which signal transmission at the MEK/ERK 
interface could be further calibrated.  
 
The phosphatase axis orients signal processing by the 
MAPK module. 
Concentrations of phosphatases frequently vary from one 
cell type to another. Further, even within a given cell type, 
either differences in environmental conditions (histories of 
stimulus) and/or developmental stages can lead to signifi-
cant changes in intracellular phosphatase concentrations 
[26,34,35]. This is particularly true for MKP’s in lympho-
cytes, where changes either in the activation or differentia-
tion state of the cell can lead to marked alteration in the 
relative levels of this class of phosphatases [26]. Thus, given 
the high connectivity between the MAPK and the phos-
phatase cascade, it was reasonable to suspect that variations 
in the relative concentration or activity of the MAPK-
associated phosphatases would have a significant impact on 
signal processing. To explore this we examined the conse-
quences of simultaneously varying the concentration of any 
two of the three MAPK-associated phosphatases, while 
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keeping the third at its constitutive level. The effects on the 
magnitude of peak phosphorylation of both MEK and ERK, 
at a fixed ligand dose, were monitored. All the three possi-
ble phosphatase combinations were tested, over a range of 
10,000 different pairs – in a 100 x 100 matrix – of their re-
spective concentrations. The range of phosphatase concen-
trations employed here was identical to that described for 
Figure 5. 
     Figure 6A depicts the results of such an exercise in 
which PP2A and MKP3 concentrations were varied, while 
keeping MKP1 at a fixed level. As shown, MEK activity 
yields a bell-shaped curve in the direction of increasing 
PP2A levels, although this profile tends to progressively 
‘flatten’ as MKP3 concentrations also increase.  While the 
inhibitory effect of MKP3 on MEK activation was mono-
tonic it was, nonetheless, buffered at high PP2A concentra-
tions (Fig. 6A). In other words, the relative concentrations 
of PP2A and MKP3 have a significant role to play in defin-
ing the sensitivity of MEK phosphorylation, to ligand-
induced stimulation of cells. This was also true in the case 
of ERK although, here, a bimodal activation profile was 
obtained in the directions of both increasing PP2A and 
MKP3 concentrations. This latter observation suggests the 
existence of compensatory effects between these two phos-
phatases, whereby multiple combinations of their respective 
concentrations yield the same level of peak ERK activity.  
     Figure 6B shows the results of a similar experiment 
where the concentrations of MKP3 and MKP1 were varied, 
under conditions where PP2A levels were kept constant. As 
may be expected, variations in MKP1 concentrations ex-
erted little or no effect on peak MEK activity and the result-
ing landscape was heavily biased in favor of the concentra-
tion-dependent inhibitory effects of MKP3. In contrast, a 
bimodal activation curve was again observed for ERK along 
the MKP3 axis. The curvature of this profile, however, was 
stringently controlled by MKP1, with ERK activation being 
completely inhibited even at moderately higher concentra-
tions of this phosphatase (Fig. 6B).  
     Similar to the results in Figure 6A, varying combinations 
of PP2A and MKP1 also yielded a bimodal MEK profile in 
the direction of PP2A, but with a significant reduction in the 
phosphatase concentration window where at least detectable 
MEK activation was allowed (Fig. 6C). With the exception 
of attenuating the amplitude of MEK activation, varying 
MKP1 levels had little effect on the profile. Qualitatively 
similar effects were also noted for ERK where increasing 
MKP1 levels served to further exacerbate the inhibition of 
ERK activation that was observed as a function of increas-
ing PP2A levels. However, here the inhibitory effect of 
MKP1 was far more pronounced. (Fig. 6C). Thus, although 
the MAPK module functions as a proportional response 
system, these results emphasize that the net output is further 
specified by the relative concentrations of the individual 
MAPK-associated phosphatases that are present. In this 
connection, the assembly of these phosphatases into a regu-
latory axis is particularly relevant. As a result, variations in 
the concentration gradient along this axis exercise a com-
binatorial influence on signal processing by the MAPK 
pathway. 
  Finally, yet another intriguing feature revealed from a cur-
sory examination of Figure 6 is the fact that the range of 
allowed concentration regimens of phosphatases was sig-
nificantly more restricted for ERK than it was for MEK. 
This was generally true for all the three pairs of phosphatase 
combinations studied where the activation landscape for 
MEK was always larger in area than that obtained for ERK 
(Fig. 6). These observations suggest that the control exerted 
by the co-aligned phosphatase axis is further accentuated 
during transmission of signal from MEK to ERK, the effec-
tor molecule of the MAPK pathway.  
 
Experimental support for a regulatory phosphatase axis. 
To confirm the above findings we examined - as a represen-
tative case - the consequences of experimentally modulating 
MKP3 levels, in conjunction with variations in the concen-
tration of active PP2A. MKP3 levels in A20 cells were al-
tered either through the use of specific siRNA, which re-
duces the amount of the protein by >70% [24], or by stably 
over-expressing it in these cells to achieve a net two-fold 
increase in its concentration (Materials and Methods). To 
modulate the concentration of active PP2A, we again em-
ployed its inhibitor OA. Thus, cells expressing either consti-
tutive, reduced (through siRNA), or increased (through 
over-expression) levels of MKP3 were individually treated 
with varying OA concentrations, and each of these groups 
were then stimulated with a range of ligand (i.e. anti-IgG) 
doses. Peak phosphorylation levels of both MEK and ERK 
were determined in each case, and the results obtained are 
presented in Supplementary Data S6 and S7.  
     We first compared these results with the predicted effects 
- on peak phosphorylation of MEK and ERK - of varying 
levels of the individual phosphatases shown in Figure 5B. 
The panel ‘a’ in Figure 7A shows an expanded region of 
these predicted profiles obtained at the higher range of 
ligand doses, and over the estimated range of either MKP3 
concentrations or PP2A activities employed in the present 
set of experiments (see Supplementary Data S8). Panel ‘b’ 
of Figure 7A depicts the experimentally obtained results 
under these conditions. A high degree of correspondence 
between the simulated and the experimentally derived pro-
files is clearly evident here. This was also equally true for 
peak MEK and ERK phosphorylation profiles in cells stimu-
lated with sub-optimal doses of the ligand. In addition to 
this, the data obtained in Supplementary Data S6 also served 
to substantiate the results of our in silico experiments de-
scribing the effects of simultaneously varying MKP3 and 
PP2A levels, on the magnitude of ERK phosphorylation 
(see Fig. 6A). A comparison of results from the two ap-
proaches is shown in Figure 7B. Here, panel ‘a’ shows the 
results of our in silico analysis performed by employing 
either a high, or a suboptimal concentration of ligand for 
cell stimulation. The corresponding profiles derived from 
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our experimental data (Supplementary Data S7) are shown 
in panels ‘b’ of these figures. Again, a good correlation be-
tween results from the two approaches is clearly evident 
here. This was also true when experimental and predicted 
results for MEK phosphorylation were similarly compared 
in terms of a heat map (data not shown). 
Thus by verifying the accuracy of the resulting predictions, 
the data in Figure 7 support the fidelity of the model de-
scribed in Figure 1A. In addition, these findings also firmly 
establish the role played by the co-associated phosphatase 
axis, in terms of further calibrating the stimulus-dependent 
responsiveness of the MAPK pathway. 
 
DISCUSSION. 
 
The remarkable versatility of the MAPK module is evident 
from the fact that ERK activation can display a wide range 
of activity profiles depending on the interfaces that regulate 
signal transmission through this module. Thus depending on 
the cell type, ERK activation can be ultrasensitive, convert-
ing graded inputs into a digital output response [10].  Em-
bedding this pathway within a positive feedback loop can 
lead to a dramatic amplification of signal, and also endow it 
with both bistability and hysteresis [19]. In contrast, a nega-
tive feedback loop combined with intrinsic ultrasensitivity 
brings about sustained oscillations in ERK phosphorylation 
[12,14]. The sensitivity of the MAPK pathway to the cellu-
lar milieu is further underscored by the fact that, under cer-
tain conditions, it can also function as a monostable system 
yielding a proportional output response at the level of ERK 
phosphorylation [36-38]. At least some of the determinants 
of the nature of input/output relationships identified so far 
are the concentration of MKPs [19], the concentration of the 
scaffolding proteins involved [15], and the extent of seques-
tration of ERK in a complex with its kinase, MEK [16]. In 
addition to defining the threshold between a switch-like 
versus a proportional response, these parameters also play a 
critical role in modulating the amplitude and kinetics of the 
output signal. 
     In the present case, the proportional nature of the in-
put/output relationship – despite incorporating a distributive 
mechanism for the dual phosphorylation of ERK - appears 
to be combinatorially defined through the relative concen-
trations/activities of the MAPK pathway-associated phos-
phatases. Thus, in silico exercises involving select modula-
tions in phosphatase concentrations yielded an enhanced 
slope for ERK activation under conditions where either PP1 
or MKP3 levels were significantly increased (Supplemen-
tary Data S10). Alterations in levels of the MAPK pathway 
components had no such effect. Consistent with this is our 
experimental demonstration that siRNA mediated silencing 
of these individual phosphatases had a significant effect on 
the amplitude, the stability, the kinetics, and the baseline 
levels of ERK phosphorylation. A role for filtering spurious 
noise by MAPK-associated phosphatases has also been re-
cently discussed [17].  
     Our finding that phosphatase-dependent regulation of 
the MAPK pathway involves organization of the phosphata-
ses into a co-aligned cascade was especially interesting. 
Traditionally, negative regulation of intracellular signal 
transduction is conceived to occur as a discrete set of local-
ized interactions between a phosphatase and its target mole-
cule, and a cascade organization for phosphatases has not 
been considered so far [26,39]. Importantly, this co-
alignment resulted in the formation of a novel regulatory 
module that was composed of a contiguous set of two 
square units with the MAPK constituents and the phos-
phatases PP2A, MKP3, and MKP1 constituting the vertices 
of these units. We have termed this novel signaling motif, 
induced upon BCR-dependent stimulation of cells, as the 
‘Signal Activated Motif’ (SAM). 
     Assembly of the SAM involved two distinct input signals 
that, in turn, separately activated the functionally distinct 
components of the module. The first of these involved the 
combined action of PKC and RasGTP to activate Raf, 
thereby initiating signal flow through the MAPK cascade. 
The second signal, on the other hand, involved the CK2α-
dependent phosphorylation of MKP3. This event was criti-
cal to the regulatory function of the phosphatase axis. Thus, 
while BCR activation activated signal flow through the 
MAPK pathway on the one hand, it also simultaneously 
embedded this pathway within a regulatory module so that 
the net signal output could be carefully regulated. 
     Central to the functioning of the SAM was the distribu-
tion of MKP3 between its phosphorylated and non-
phosphorylated states where the balance between these two 
forms was defined by the reciprocal actions of the constitu-
tively active PP2A, and the signal- activated CK2α. This 
segregation of input signals to activate both the positive and 
negative regulatory components of the SAM motif provided 
the mechanism by which filtration and appropriate calibra-
tion of the signal output could be achieved. Key to this was 
the differential substrate bias displayed by phosphorylated 
and non-phosphorylated MKP3, with the relative proportion 
of these two subsets being governed by the extent to which 
the input signal (i.e. activated CK2α) could buffer the action 
of PP2A. The conditional shifts in the equilibrium between 
these two pools played a critical role in defining the signal 
output in terms of the ERK activation profile. In other 
words, this ability to modulate substrate preferences enabled 
MKP3 to function as an additional response element for 
signal discrimination whereby both signal amplitude and 
sensitivity to ligand concentration could be further tuned. 
     Our subsequent analysis of how output responses were 
shaped by alterations in phosphatase concentrations also 
provided interesting new insights into the properties of the 
SAM. While MKP3 levels were important in defining the 
amplitude of ERK activation, it was the MKP1 concentra-
tions that strictly defined the window of ERK activation. 
That output regulation involved the coordinated action of 
associated phosphatases was also emphasized in our studies 
examining the effect of simultaneously varying concentra-
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tion of two phosphatases. For example, the available levels 
of the remaining two phosphatases further modulated the 
effects of varying MKP3 concentrations. This was equally 
true for PP2A and MKP1, thereby reaffirming the signal-
dependent assembly of these phosphatases into a functional 
axis that intimately regulates signal processing. 
     The net outcome of the coordinated action of phosphata-
ses was that information flow through the MAPK pathway 
did not occur in a linear fashion. Rather, signal was differ-
entially processed at each intermediate in the pathway. Con-
sequently, in addition to strength of the stimulus, transmis-
sion of signal between successive nodes was also rendered 
sensitive to the relative concentrations of the associated 
phosphatases. Thus, for example, conditions yielding a po-
tent activation of MEK did not necessarily translate into a 
similar profile for ERK. Instead, signal transmission from 
MEK to ERK was additionally regulated by the activity 
and/or concentration of the two remaining phosphatase 
components of the SAM. The resultant combinatorial effects 
then ranged from a marked amplification, to a complete 
suppression, of ERK activation. Indeed even the limited 
investigations performed here reveal how the intricate cou-
pling of a kinase with a phosphatase axis can provide for 
flexible regimes of regulation where the activity and/or con-
centrations of the participating phosphatases make key con-
tributions to calibration of the signal output. A direct conse-
quence of this was an expanded landscape of potential ERK 
responses where a given output characterized not only the 
strength of activating stimulus, but also the phenotypic state 
of the cell – at least when characterized in terms of the 
MAPK-associated phosphatase milieu. 
      Differences in the tissue-specific origin of cells are also 
often reflected at the level of differences in concentration of 
the individual MKPs. Similarly, variable MKP levels fre-
quently characterize the individual stages of lineage com-
mitment in lymphocytes [40]. Further, even within a given 
cell type, activation of ERK leads to the upregulation of 
both MKP1 and MKP3 [26], with the consequent de-
sensitization of ERK to any further stimulation of the cell. 
Thus, the composition of at least MKPs within a cell may 
well provide a phenotypic description of its activation 
and/or differentiation status, which then is also incorporated 
when defining the ERK output response. 
     Thus, in summary, our present delineation of an emer-
gent motif that endows the MAPK pathway with flexible 
regimes for modulating signal output provides additional 
insights into mechanisms that facilitate information process-
ing by the signaling machinery. At one level, these findings 
reveal a novel organizational principle wherein a kinase 
cascade is intricately coupled to a regulatory cascade of 
phosphatases. The resulting structural motif that links each 
kinase intermediate to both the iso-stage, and the upstream 
phosphatase ensures that signal transmission is subjected to 
tight scrutiny at every step of the pathway. This allows the 
‘strength’ of the links between the phosphates axis and the 
kinase cascade to also function as determinants of signal 
processing. As a result, even a simple proportional re-
sponse system becomes endowed with the ability to gener-
ate an output that, in addition to signal duration and 
strength, is also sensitized to variations in phosphatase con-
centrations and activities. As noted earlier, such variation 
could potentially encapsulate differences in the phenotypic 
status of cells either at the level of cell type, differentiation 
state, or, the history of prior stimulations. It, however, re-
mains to be seen whether such a regulatory module is also 
associated with the other pathways of the signaling network. 
 
 
 
MATERIALS AND METHODS. 
 
Model building and numerical simulations: 
A complete description of model building and de-
tails of the reaction scheme is provided in the Supplemen-
tary data S1 (Description of model). All reactions were con-
verted into molecule-molecule interactions defining either 
binding interactions, or catalytic reactions. We have used 
Simbiology2.2 (Mathworks) on MATLAB7.5 as a platform 
for implementing the model and for carrying out numerical 
simulations. All calculations except for that of restimulation 
experiments were done using ode15s, which is a solver for 
stiff differential equations and DAE. It uses the variable 
order method based on numerical differentiation formula for 
stiff differential equations. Restimulation experiments were 
done using Sundials solver CVODE provided with Simbiol-
ogy. Parameters were either taken from literature or esti-
mated. Estimation of unknown parameters was done either 
by iteratively fitting to the experimental constraints, or by 
using local optimization with lsqnonlin, lsqcurvefit (wher-
ever experimental data was available for immediate read-
out). Sensitivity analysis of the complete model was done 
by using SBML_SAT [41], a freely available SBML-based 
MATLAB toolbox available at 
(http://sysbio.molgen.mpg.de/SBML-SAT/).  
 
Stimulation of cells and detection of phosphoproteins 
A20 cells (1 107/ml) were stimulated with the F(ab)2 
fragment of goat anti-mouse IgG at a final concentration of 
25 μg/ml in RPMI for a period of up to 30 min [23]. At 
appropriate times, aliquots of cells were collected, 
centrifuged, and the cell pellets stored in liquid nitrogen. 
When required, cells were lysed, the detergent-soluble 
proteins resolved by SDS–PAGE, and specific proteins and 
phosphoproteins detected (and quantified) by Western blot 
using the procedure and antibodies as previously described 
[24].  
 
Co-Immunoprecipitation: 
Lysates were prepared from 2 x 107 cells/group/time point 
in a buffer containing a cocktail of protease and phosphatase 
inhibitors as previously described [23]. Lysates were pre-
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cleared with protein A-agarose and then incubated with ap-
propriate antibody (0.6 – 1 mg, at 4oC for 2h), after which 
the immune-complexes were precipitated with protein A-
sepharose. The immunoprecipitates were identified by im-
munoblotting with specific antibodies (Santa Cruz Biotech). 
 
Over-expression of MKP3 in A20 cells. 
MKP3 was over-expressed as a Strep-tag II fusion protein in 
A20 cells[42]. For this the cDNA was cloned into the 
pEXPR-IBA103 vector and then transfected into cells by 
electroporation. Subsequent selection for neomycin resis-
tance over a 4-week period yielded stably-transfected cells. 
A Western blot analysis revealed that these cells expressed 
about 2-fold higher levels of MKP3 when compared to un-
transfected A20 cells. 
 
Confocal Microscopy: staining and image analysis. 
Immuno-fluorescence staining was performed following the 
standardized protocol reported previously (Kumar et al, 
2008). Stained cells were observed with a Nikon TE 2000E 
microscope equipped with 60X/1.4NA PlanApochromat 
DIC objective lens. Secondary antibodies tagged either with 
Alexa 488 or Alexa 568 were excited at 488 nm and 543 nm 
with an argon ion- and a Helium-Neon laser respectively. 
The emissions were recorded through emission filters set at 
515/30; 605/75. Serial confocal sections (0.5 μm thick) 
within a z-stack spanning a total thickness of 10-12 μm 
were taken in individual channels green and red using the 
motor drive focusing system. The transmission and detector 
gains were set to achieve the best signal to noise ratios and 
the laser powers were tuned to limit bleaching fluorescence. 
The refractive index of the immersion oil used was 1.515 
(Nikon). All settings were rigorously maintained for all the 
experiments. All images were quantified using Image-Pro 
Plus version 6.0, a commercially available software package 
from Media Cybernetics. 
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FIGURE LEGENDS: 
 
 
Figure 1: Signaling through the Lymphocyte receptor 
induces a novel regulatory motif for MAP kinase activa-
tion. 
A schematic overview of the reactions for BCR dependent 
activation of MAP kinase ERK-1/2 is shown in Panel A. 
The highlighted area represents the novel signaling motif 
identified and this is expanded in panel B.  
 
Figure 2: The ERK phosphorylation response is propor-
tional to the stimulus strength. 
Panel A shows the concordance obtained between experi-
ment (red diamonds, values as mean ±S.D., n=3) and simu-
lation (black line) examining the time course of ERK phos-
phorylation obtained upon stimulation of A20 cells with a 
saturating (25 μg/ml) concentration of anti-IgG. Panel B 
shows the results of an in silico analysis estimating the 
magnitude of ERK phosphorylation obtained after stimula-
tion of cells with varying anti-IgG concentrations. Panel C 
gives the corresponding results of an experiment where A20 
cells were stimulated for 10 min, with the indicated doses of 
anti-IgG. ERK phosphorylation was then determined in lys-
ates by Western blot analysis (see Supplementary Data S4). 
Values are the mean (±S.D.) of three independent experi-
ments. A semi-log plot of these results yielded a Hill coeffi-
cient of 0.6 and 0.56 for simulated and the experimental 
results respectively. Stimulated cells were also subjected to 
staining for intracellular phospho-ERK using specific anti-
bodies followed by FITC-labeled secondary antibodies. 
Stained cells were then analyzed by flow cytometry and the 
results are shown in panel D. Depicted here are the profiles 
obtained for cells stimulated with either 0.1 (black line), 0.5 
(green line), 5 (pink line), or 25 μg/ml (blue line) of anti-
IgG. The profile for unstimulated cells overlapped with that 
for cells stimulated with 0.1 μg/ml of ligand. For the nega-
tive control, cells were stained with rabbit IgG instead of the 
anti-phospho-ERK antibody.  
 
Figure 3: Verification of novel interactions incorporated 
in the model 
In panel A, lysates from stimulated or unstimulated A20 
cells were immunoprecipitated with antibodies specific ei-
ther for MKP3, MEK, or MKP1 (Materials and Methods) 
(left column, IP). Immunoprecipitates were then subjected 
to a Western blot analysis using the antibodies indicated in 
the right column (WB). As a negative control (ctrl), parallel 
immunoprecipitates with rabbit IgG were also probed with 
the corresponding antibodies. 
     Panel B shows the results of Western blot analyses for 
MKP1 in A20 cells treated either with MKP3-specific 
siRNA (red line), or with non-silencing (i.e. GFP-specific) 
siRNA (blue line). Stimulation times with anti-IgG (25 
μg/ml) are indicated, and values are the mean ± S.D. of 
three separate experiments. We have previously demon-
strated that siRNA-mediated silencing of MKP3 results 
in a >70% reduction of this phosphatase protein in A20 cells 
[22]. 
     In Figure 3C the top panel shows the effect of DRB 
(30μM) on the anti-IgG dependent phosphorylation of ERK. 
The lower panel shows the corresponding profiles obtained 
from an in-silico analysis. The blue color identifies the pro-
files obtained in the absence of any inhibitor, whereas the 
pink color denotes the profiles obtained in the presence of 
DRB. For the experiment in panel D, A20 cells were stimu-
lated for 10 minutes with anti-IgG in the presence or ab-
sence of casein kinase inhibitor DRB (20μM). Cells were 
then fixed and stained for ERK1/2 and MKP3 (top panel), 
MEK1/2 and MKP3 (middle panel), or MKP1 and MKP3 
(bottom panel) and observed under laser scanning confocal 
microscope (Materials and Methods). Merged images for 
co-localization between green (ERK1/2, MEK1/2, or 
MKP1) and red (MKP3) are shown in the figure. The quan-
titative differences between DRB treated and untreated cells 
for co-localization with MKP3-MEK1/2, MKP3-ERK1/2, 
MKP3-MKP1 upon anti-IgG treatment are shown in panel 
E. Values are the average (± S.E.) of over at least 40 cells 
(*** p < 0.0005; ** p < 0.005). 
 
Figure 4: Phosphatase-mediated regulation of the 
MAPK signaling response.  
The influence of individual phosphatases in sensitizing the 
ERK output was monitored in-silico by analyzing ligand 
dose versus peak phospho-ERK levels within the first 30 
min of activation. This analysis was performed either in 
normal cells (Normal), or in cells where the indicated phos-
phatase was depleted from the system. In each panel, the 
fold change in ligand concentration required to increase 
ERK phosphorylation from 10% to 90% of its maximal 
value is also given (F). These values confirm that the ERK 
response remains proportional under all of these conditions.  
 
Figure 5: Modulation in phosphatase concentrations 
further shape ligand-sensitivity of the MAPK pathway. 
Peak phosphorylation of ERK (ppERK) and MEK (ppMEK) 
was monitored in response to variations in both ligand and 
individual phosphatase concentrations. Three separate sets 
of simulation, within a defined concentration window, were 
used to reduce the computing time. For each phosphatase, 
100 different concentrations of phosphatase were used, 
varying from 10 times lower to 10 times higher than its con-
stituent concentration level in A20 cells. The combined data 
is plotted here. Figure 5A profiles peak phospho-MEK lev-
els as a combined function of both varying ligand doses, and 
varying concentrations of each of the three phosphatases. 
Here, the top panel shows the 3-dimensional plot, while the 
lower panel depicts the same results in the form of a heat 
map. Similarly, panel B shows peak phospho-ERK levels as 
a combined function of both ligand dose and varying con-
centrations of the three phosphatases.  
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Figure 6: Inter-phosphatase crosstalk regulates signal 
transmission through the MAPK pathway. 
The effects of simultaneous variations in the concentration 
SAM-associated phosphatases on peak phospho-MEK 
(ppMEK) and peak phospho-ERK (ppERK) levels within a 
30-minute activation window are shown here. A total of 100 
different concentrations were employed for each phos-
phatase. These varied from 10 times lower, to 10 times 
higher than the constituent concentration in A20 cells. The 
three combinations shown here are MKP3-PP2A (A), 
MKP3-MKP1 (B) and PP2A-MKP1 (C). In each case the 
top panel shows peak phospho-MEK levels, while the lower 
panel shows peak phospho-ERK responses. The left and the 
right panels depict the 3-dimensional landscape, and the 
corresponding heat-map representation respectively. The 
corresponding profiles for the remaining components of the 
module that are also regulated by phosphorylation (i.e. Raf, 
MKP1, and MKP3) are shown in Supplementary Data S9. 
 
Figure 7: Experimental confirmation of the systems 
properties of the MAPK-associated regulatory module. 
Panel A depicts MEK and ERK phosphorylation levels ob-
tained as a function of changes either in MKP3 or PP2A 
concentrations as described in the text. For the profiles ob-
tained in silico (Predicted), the concentration ranges utilized 
is described in Supplementary Data S8, whereas the extent 
of variation in phosphatase concentration/activity obtained 
experimentally (Experimental) is described in the text. The 
anti-IgG concentrations employed for the experiment in 
high ligand dose (upper panel) were 10 (blue line) and 25 
(red line) μg/ml; whereas for low ligand dose (lower panel) 
it was 0.05 (blue line) and 0.5 (red line) μg/ml.  
Panels B describes the effects of combined variations in 
levels/activities of both MKP3 and PP2A, on the magnitude 
of ERK phosphorylation. Here again a comparison between 
the in silico (Predicted), and the experimentally (Experi-
mental) obtained results is shown. Although a similarity in 
profiles between the two groups is clearly evident, the ab-
sence of a higher degree of concordance was primarily due 
to the limited number of data points in the experimental 
group. As described in the text, MKP3 levels were varied in 
the Experimental sets either through specific depletion by 
siRNA (KD), or by over-expression (OE). 
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Complete description of the Model 
 
 The BCR is composed of heavy and light chains 
and the associated immuno-tyrosine activation motifs 
(ITAMs). ITAMs get phosphorylated in response to BCR 
engagement by antigen, which then leads to cross linking of 
the BCR molecules. The BCR dependent phosphorylation of 
ITAMs is sustained through Syk dependent phosphorylation 
on three additional sites on the ITAMs. For simplicity, how-
ever, we have defined all stages of this multiple phosphory-
lated states as the doubly phosphorylated BCR (which 
represents- ITAM + Immunoglobulin part of the BCR). 
Both singly and doubly phosphorylated BCR activates the 
src kinase Lyn. Syk, which is immediately downstream to 
Lyn, is then phosphorylated in a Lyn-dependent manner. 
This establishes a positive feedback loop at the BCR[1]. 
Antigen-bound BCR also undergoes internalization, al-
though internalized receptors do not contribute towards fur-
ther signaling[2]. Lyn also phosphorylates CD22, a mem-
brane anchored intermediate of B cell signaling. This, in 
turn, recruits the protein tyrosine phosphatase SHP1 to the 
membrane. Since SHP1 is a negative regulator of a majority 
of protein tyrosine kinases including Lyn and Syk, a nega-
tive feedback loop is established. Thus a negative and a 
positive feedback loop are both established in the immediate 
vicinity of the BCR. Both Lyn and Syk also activate 
Brutons’ tyrosine kinase (Btk). Btk in turn phosphorylates 
PLCg when the latter is bound to the Syk-phopshorylated 
BLNK, a major scaffold protein that connects BCR initiated 
signaling to downstream events[3,4]. Lyn via CD19, and 
Syk via BCAP (B Cell Adopter Protein), activate PI3-
Kinase signaling with the consequent generation of PIP3. 
This leads to recruitment of cytoplasmic Akt and PDK to 
the membrane, where PDK then phosphorylates Akt[4]. 
 Syk mediated activation of BLNK also leads to the 
formation of a BLNK-Grb2-SoS complex, which functions 
as the RasGDP-GTP exchanger in B cells. The GAP and 
GEF are modeled according to the scheme as described by 
Bhalla et. al.[5,6]. We’ve summarized the activation of all 
PKC isoforms by DAG mediated PKC recruitment to the 
membrane. RasGTP binds to Raf and resulting complex of 
Raf-RasGTP is then phosphorylated by PKC. Phosphory-
lated Raf activates the classical Raf-MEK-ERK pathway. 
Although lymphocyte signaling also involves RasGRPs in 
activation of RasGTPs via SOS[7,8], the effect of RasGRPs 
are better characterized in terms of maintaining the basal 
levels of RasGTP activity[8]. The stimulus induced effect of 
RasGRPs on RasGTP kinetics is still unclear. Therefore, we 
kept our model at the level of RasGTP simple and invoked 
only the classical activation pathway of RasGTP via SoS as 
the standard GEF. The predicted ligand dose response 
yielded a good match with the experimental results and 
more importantly the simplification of the activation path-
way of RasGTP did not affect the performance of our 
model.  ERK negatively regulates Raf by hyper phosphory-
lating it[6,9]. In addition Raf is also negatively regulated  
through phosphorylation at ser259 by activated Akt [10]. 
This  process has been modeled accordingly. Dephosphory-
lation of activated Raf is mediated through PP2A whereas 
the inactivated form represented by hyperphsophorylation or 
Ser259 phosphorylation, is dephosphorylated  by both PP1 
and PP2A. 
Several reports in the literature have indicated that 
phosphorylation of ERK1/2 is also regulated by phosphata-
ses[6]. In more recent experiments we have demonstrated 
that the BCR dependent phosphorylation profiles of all the 
three constituents of the MAPK module (i.e. Raf, MEK1/2 
and ERK1/2) were profoundly influenced when cells were 
depleted of a range of cellular phosphatases by siRNA. In-
terestingly, depending upon the phosphatases that were de-
pleted, both negative and positive effects were noted sug-
gesting the existence of diverse modes of regulation [11]. 
Therefore to explore this further, we also incorporated these 
earlier results for five phosphatases. These were PP1, PP2A, 
MKP1, MKP2 and MKP3. We started by linking core 
MAPK module recursively with the phosphatases in a man-
ner that satisfied the experimental data. The phosphorylation 
profile of ERK was used as eventual output, although the 
simulated profiles of Raf and MEK1/2 were also compared 
with the experimental data for the purpose of model valida-
tion. 
Whereas PP1(or, Calcineurin) was treated as an un-
regulated pool, the dual specificity phosphatases MKP1 and 
MKP3 were modeled as previously described[6], but with 
the modification that phosphorylation of MKP1 was mod-
eled as a single step process. An interesting aspect of our 
earlier experimental results was the finding that depletion of 
MKP3 by siRNA resulted in contrasting effects on the BCR-
stimulated phosphorylation profiles of MEK and ERK. 
Whereas phosphorylation of MEK-1/2 was markedly en-
hanced, the sensitivity of ERK-1/2 to BCR stimulation was 
attenuated[11]. This observation could be rationalized by 
invoking the related finding of [12], that the PKC substrate 
Casein kinase2α both interacts with and phosphorylate 
MKP3. Thus, although MKP3 is known to negatively regu-
late ERK1/2 activation, the simultaneous over-expression of 
CK2α – however reversed this effect. This attenuating effect 
of CK2α on MKP3 involves phosphorylation of the lat-
ter[12]. In our present system we found that MKP3 expres-
sion was up regulated upon BCR stimulation (S3c.B) and 
our model depicts that the interaction of CK2αwith this 
phosphatase modulates the MKP3-mediated co-ordination 
of the negative feedback loop influencing ERK-1/2 phos-
phorylation. Importantly our earlier results also implicated 
MKP1, which is positively regulated by ERK-1/2 as a direct 
target of MKP3. While modeling the MAPK pathway, how-
ever, the possibility that the MKP3 acted simultaneously on 
both ERK-1/2 and MKP1 seemed unlikely since such a 
proposition failed to explain the previously described ex-
perimental results. We therefore, considered the possibility 
that the ERK-1/2 and MKP1 may represent alternate sub-
strate for MKP3, with substrate specificity being determined 
Supplementary Data S1A 
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by the phosphorylation state of MKP3. Whereas the non 
phosphorylated MKP3 functioned as a negative regulator of 
ERK-1/2 activation, its phosphorylation by CK2α alters its 
substrate preference in favor of MKP1, with the consequent 
attenuation of its activity. This postulates yielded a satisfac-
tory solution after a few optimization and simulation exer-
cises. 
Our earlier findings that the depletion of MKP3 
from cells by si-RNA resulted in a marked enhancement in 
the BCR-dependent phosphorylation of MEK-1/2 [11] also 
prompted us to link phosphorylated MKP3 as a negative 
regulator of MEK-1/2. Consequently, while phospho-MKP3 
would not be expected to directly inhibit ERK-1/2 activation 
this would nonetheless, be compensated by the inhibitory 
effect of MKP3 on the upstream kinase MEK-1/2. Further, 
PP2A has been described as a regulator of the phosphoryla-
tion of MEK-1/2[5,6,13]. In addition, a marked increase in 
ERK-1/2 phosphorylation was also observed under these 
conditions. We accounted for these unexpected findings by 
considering the possibility that phosphorylation of MKP3 
could be reversed by the direct action of PP2A. Thus in ad-
dition to de-phosphorylating Raf and MEK-1/2, PP2A is 
also likely to function in regulating the balance between the 
phosphorylated and non-phosphorylated pools of MKP3. 
The resulting model for the MAPK module yielded a predic-
tion for the time dependent phosphorylation of ERK-1/2 that 
was in excellent agreement with the experimentally obtained 
results. 
The above results thus identify a cascade of phos-
phatases (PP2A-MKP3-MKP1) that is aligned in parallel 
with the MAPK cascade (Raf-MEK-ERK). ERK activation 
also leads to transcriptional up-regulation of MKP1 and 
MKP3. We have achieved the same through a reaction 
scheme similar to as proposed by [6], although the rates are 
scaled according to the present concentration of these two 
phosphatases. The concentrations of c-Raf, MEK, ERK, 
PP2A, MKP1, RasGDP-GTP total, Akt were determined by 
Western blot titrations that compared against corresponding 
levels present in NIH3T3 and CHO cells (Data not shown 
here). Concentrations of the remaining molecules were es-
timated. 
Assumptions and criteria for implementation of the 
model : 
Few important Considerations have been taken while im-
plementing model in mathematical form which are as fol-
lows: 
1. Since a detailed description of the early signaling 
events at the BCR signalosome is currently un-
available, the steps were minimized and unneces-
sary complexity was avoided. For this, the parame-
ters were constrained to the extent possible for de-
scribing the kinetics of these events without affect-
ing the known outputs, and keeping the system 
simple. For example, phosphorylation of BLNK at 
multiple sites was represented by a single step. Fur-
ther, the four different (1+ 3) events of phos-
phorylation at the ITAMs (BCR in the model)  by 
BCR activation and Syk mediated feedback were 
simplified in two steps (1 by BCR engagement + 1 
by Syk) keeping the positive feedback effect of 
Lyn-Syk-ITAM feedback loop intact. 
2. Activated to unactivated ratios were maintained for 
different molecules in accordance with their cyto-
plasmic locations and mode of activation. Com-
partmentalization was not considered in our analy-
sis. 
3. In the case of regulation by multiple phosphatases, 
the experimental results obtained by Western blot 
analyses cannot be directly correlated to exact rela-
tive levels of activated molecules since quantitation 
by this technique is not linear over a large range. 
Thus a true regression scheme cannot be employed 
for phosphatase-mediated perturbations involving 
large variations in phosphorylation levels. Further, 
shifts in baseline phosphorylation levels also cause 
problems, which are not usually encountered in the 
traditional model building exercises where maxi-
mum phosphorylation levels of substrates follow-
ing on receptor activation are considered as 100%, 
and regression is then applied for a comparatively 
smaller range of modulations in phospholevels. 
However post implementation techniques were 
employed for assessing regression stability of the 
parameters. These were Multi Parametric Sensitiv-
ity Analysis (MPSA) and Partial Rank Correlation 
Coefficients (PRCC), as described later in sensitiv-
ity analysis and robustness scores. 
4. Parameters describing the kinetics of molecules on 
the network periphery were grouped together to de-
fine the representative kinetic behavior relevant to 
the present MAPK module. 
 
Robustness of the Model: 
 
Our present model was unique in that it also mod-
eled active regulation by phosphatases. It included active 
regulation of phosphatase by the kinase components of the 
network, which in turn was negatively regulated by these 
active phosphatases. Thus it became important to test the 
model for its robustness to the parameter variations, at least 
to the extent that it compared well with existing models. 
Robustness is a fundamental property of biological systems, 
which allows the systems to maintain its behavior against 
random perturbations [14,15]. We preformed the Robust-
ness analysis by SBML_SAT [16]. Robustness analysis was 
performed as described [17,18], and Robustness scores 
measured as Total Parameter Variations (TPV) by  ran-
domly generated parameters by  Latin Hypercube Sampling 
method. 
The R scores (Robustness scores) of a biological 
components of those models, calculated under identical 
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conditions of perturbations, are given in Table S1.2. As is 
evident here, the robustness score of our model compares 
well with that of the others, particularly with those that take 
phosphatases into consideration. Our model shows a par-
ticularly good agreement with that of Bhalla et.al. (2002); 
model assumes a negative value and the closer this value is 
to zero, the more robust the model. Here we compared some 
of the models for the MAPK pathways in the literature with 
our present model. The corresponding R scores of MAPK 
the only other model that incorporates active regulation of 
the phosphatase MKP1. 
Table S1.2: Comparison of the robust scores of various Models of MAPK : 
 
Model Name Receptor/ 
Activator 
RasGTP pMAPKKK ppMAPKK pMAPK Phosphatase 
Regulation 
Huang Ferrell -0.00543320 ------- -0.662038 -0.961861 -1.23605 No 
Kholodenko 
2000 
------- ------- -0.537109 -1.00071 -1.25602 No 
Levchenko 
With scaffold 
------- ------- -0.344902 -0.67925 -1.11045 No 
Levcheno 
No Scaffold 
------- ------- -0.561329 -1.3463 -2.80383 No 
Hatakeyama 
2003 
-0.58779 -1.53691 -1.59975 -1.78692 -3.52799 Phosphatases 
Buffered 
Sasagawa -0.472733 -0.79791 -0.875844 (cRaf) 
-0.980000 (BRaf) 
-1.2053 -1.99484 Phosphatases 
Buffered 
Bhalla 2002 -1.44197e-034 -0.158336 -0.88649 -3.01403 -5.13613 MKP1 Regulation 
by MAPK 
 Present Study -0.386837 -0.980019 -1.34911 -2.27352 -4.98263 Active phosphatase 
cascade. 
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Figure S2. Shown here is a simulation of the time course of phosphorylation Raf (pRaf) and MEK (ppMEK) in
cells stimulated with a saturating concentration of ligand. The inset in each panel gives the peak level of
phosphorylation obtained over a wide range of ligand concentrations. These profiles are consistent with the the
experimental results derived in our earlier studies(Kumar et. al., 2007, 2008) The concordance between the 
experimental (red diamonds, values are mean + S.D. of three experiments) and the simulated profiles is shown for 
ppMEK. 
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Figure S3. Panel A shows simulation of the time course of phosphorylation of the indicated molecules in cells 
stimulated with a saturating concentration of the ligand. For the purposes of comparison, the experimentally derived 
values at the various time points are also included (red diamonds, values mean ± S.D. of three experiments). These 
values are from our earlier study (Kumar et. al., 2007, 2008). For the in silico profiles simulations were first run for 
3000 seconds to achieve the steady baseline levels of phosphorylations prior to stimulation. This explains the 
baseline levels of phospho-species seen in these profiles. Panel B compares the experimentally derived 
(Experimental) and in silico (Simulated) profiles of ERK phosphorylation following depletion of cells with the 
indicated phosphatases. The values for the experimental group were taken from Kumar et. al. (2008). In all cases the 
X-axes start from zero although the units are arbitrary. In all the panels the profiles obtained in mock (i.e. GFP-
siRNA) treated cells are shown in blue whereas those for phosphatase-specific siRNA treated cells are in red. For the 
in silico profiles simulations were first run for 3000 seconds to achieve the steady baseline levels of ERK 
phosphorylations prior to stimulation. This explains the minor lag period seen in these profiles. 
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Supplementary Data S4
A 
Effect of MKP3 knock down by siRNA on MKP1 expression 
level
Figure S4. Panel A shows the Western blot profile of MEK in A20 cells treated either with non-
silencing (GFP) siRNA (labeled Normal), or with MKP3-specific siRNA. In both cases the cells were
stimulated with the F(ab)2  fragment of anti-mouse IgG for the indicated times. For quantification band
intensities were normalized against that obtained for PLCg, which was used as loading control. Panel B
shows the stimulation time-dependent phosphorylation profiles of ERK (ppERK) in either treated cells, or
in cells pre-treated with DRB. GAPDH (Ctrl) served as the loading control for band intensity normalization
in these experiments. Shown in Panel C are the time dependent phosphorylation profiles of ERK (ppERK)
at the indicated concentrations of ligand. Here again, GAPDH was used for the loading control and for
normalization of band intensities.  
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Figure S5. The peak phosphorylation of MEK (ppMEK, top subpanel) and ERK (ppERK, bottom 
subpanel) was determined in response to variations in concentrations of both ligand and either PP1 or 
MKP2. The remaining details are identical to that described for Figure 5 in the main text. 
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Supplementary Data S5
Figure S6:Ligand dose response of MEK and ERK phosphorylation to variations in levels of 
phosphatase activity. Shown here are the Western blot profiles for both the MEK and ERK protein, and its 
phosphorylated form in either normalA20 cells, in cells treated with MKP3 specific siRNA, or in cells 
transfected with an MKP3 bearing plasmid (see Experimental Procedures). For each group and condition, 
cells were stimulated with the indicated concentration of ligand, and the level of phosphorylation monitored 
10 min later. The relatively lower intensities of the MEK blots are due to the fact that the concentration of 
this protein is about 6-fold lower than that of ERK in these cells (Supplementary Data S1)
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FigureS7:  Modulation of dose response by varying phosphatase concentrations: Western Blots in 
Figure S-6 were normalized and quantified using our toolbox (Gel-norm) as described earlier (Kumar et. 
al., 2007). The plots of these values are shown here.
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Figure S8. Panel A of this figure gives the simulated profile of peak phospho-ERK (ppERK) levels under conditions where 
concentrations of either MKP3 or PP2A  ranged from 10-fold lower, to 10-fold higher than their respective levels in A20 cells. ERK 
phosphorylation responses at both high and low ligand doses are shown here. In each profile the boxed region indicates the 
concentration (for MKP3), or activity (for PP2A) range that was taken for the experiments described in Figure 7A of the main 
manuscript. Similarly MEK profile for prediction were also obtained.
Panel B shows the results of a simulation experiment where peak phospho-ERK responses were monitored under conditions where the 
concentrations/activities of both phosphatases were derived from the same range as described for Panel A. Here again, results obtained 
at high and low ligand doses are shown. The top part of this panel gives the results obtained over all the combinations of PP2A and 
MKP3 concentrations tested, and the boxed region identifies the range represented by the experiments in Figure 7B of the main 
manuscript. The lower part of this panel shows a magnification of this boxed region. 
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Figure S10 : This Figure represents a part of the experiment performed in Figure 6 of the
main manuscript. Shown here are the effect of variation in concentrations of the
indicated phosphatase pairs on peak phosphorylation levels of Raf (pRaf), MKP1
(pMKP1), and MKP3(pMKP3). It is notable that, as per our expectations from the model
in Figure 1A, the amplitude of Raf phosphorylation is only weakly sensitive to changes
in concentration of PP2A. According to our model, the effect of altered PP2A levels is
buffered by the excess of available PP1.(In all cases arrows showing minimum to
maximum conc. of the corresponding enzymes) 
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Figure S10. Panel A of this figure shows the effect of varying phosphatase
concentrations on the ligand dose sensitivity of ERK phosphorylation. Here ERK
phosphorylation was measured at 30 minutes of stimulation. Both the ligand dose
employed and the phosphatase concentrations tested, are indicated. A marked effect of
phosphatase concentration on the dose response profile is clearly evident in all the cases.
However only an increase in either PP1 or MKP3 levels led to sharp increase in the slope
for ERK activation. Contrary to the findings for another cell line (Bhalla et. al., 2002),
modulation of MKP1 concentrations did not yield an ultrasensitive response. This is
probably because of the absence of the previously described feedback loop since cPLA2
is not expressed in mature lymphocytes. Finally, no trend towards ultrasensitivity could
be detected upon varying the concentrations of the MAPK pathway constituents Raf,
MEK, ERK. 
Panel B shows the dose response profile for ERK phosphorylation obtained following a
3- fold increase in the concentration of either PP1 (blue line) or MKP3 (Green line)
under conditions where the MKP1 levels was reduced by tenfold relative to the
experimentally determined values in A20 cells. Thus the shape of the ERK output
response to BCR stimulation clearly reflects a combinatorial outcome of the relative
concentrations of the individual MAPK pathway-associated phosphatases 
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